Nemaura Medical Inc. Note Agreements
9 Contracts & Agreements
- Secured Promissory Note issued by the registrant, Dermal Diagnostics Limited and Trial Clinic Limited in favor of Streeterville Capital, LLC (Filed With SEC on November 21, 2023)
- Secured Promissory Note, dated as of May 20, 2022, issued by Nemaura Medical Inc (Filed With SEC on November 14, 2022)
- Note Purchase Agreement, dated as of May 20, 2022, by and among Nemaura Medical Inc., Dermal Diagnostics Limited, and Trial Clinic Limited and Streeterville Capital, LLC (Filed With SEC on November 14, 2022)
- Amendment to Secured Promissory Note, dated as of October 21, 2022, by and among Nemaura Medical Inc., Dermal Diagnostics Limited, Trial Clinic Limited and Uptown Capital, LLC (Filed With SEC on October 26, 2022)
- Secured Promissory Note of the Registrant issued to Uptown Capital, LLC dated February 8, 2021 (Filed With SEC on February 11, 2021)
- Investor Note #2 dated April 15, 2020 issued by Chicago Venture Partners, L.P. in favor of the registrant, Dermal Diagnostics Limited and Trial Clinic Limited (Filed With SEC on April 21, 2020)
- Investor Note #1 dated April 15, 2020 issued by Chicago Venture Partners, L.P. in favor of the registrant, Dermal Diagnostics Limited and Trial Clinic Limited (Filed With SEC on April 21, 2020)
- Secured Promissory Note dated April 15, 2020 issued by the registrant in favor of Dermal Diagnostics Limited, Trial Clinic Limited and Chicago Venture Partners, L.P (Filed With SEC on April 21, 2020)
- Note Purchase Agreement dated April 15, 2020 by and among the registrant, Dermal Diagnostics Limited, Trial Clinic Limited, and Chicago Venture Partners, L.P (Filed With SEC on April 21, 2020)
